1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
250.64%
Some net income increase while 1097.HK is negative at -126.25%. John Neff would see a short-term edge over the struggling competitor.
-23.30%
Negative yoy D&A while 1097.HK is 0.07%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-963.72%
Negative yoy working capital usage while 1097.HK is 52.02%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
24.61%
Some inventory rise while 1097.HK is negative at -174.10%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
-1099.00%
Negative yoy usage while 1097.HK is 52.40%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
14.73%
Lower 'other non-cash' growth vs. 1097.HK's 129.06%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-1.48%
Both yoy CFO lines are negative, with 1097.HK at -32.82%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-27.12%
Negative yoy CapEx while 1097.HK is 19.25%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-100.00%
Negative yoy acquisition while 1097.HK stands at 100.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
100.00%
Purchases growth of 100.00% while 1097.HK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-100.00%
We reduce yoy sales while 1097.HK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
42.34%
Less 'other investing' outflow yoy vs. 1097.HK's 185.30%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
-231.73%
We reduce yoy invests while 1097.HK stands at 38.22%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
754.15%
We slightly raise equity while 1097.HK is negative at -100.00%. John Neff sees competitor possibly preserving share count or buying back shares.
No Data
No Data available this quarter, please select a different quarter.